1200575-71-8

Basic information

• Product Name: (1-methylcyclopropyl)methyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate
• Synonyms: (1-methylcyclopropyl)methyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate
• CAS NO: 1200575-71-8
• Molecular Weight: 465.546
• Mol File: 1200575-71-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1-methylcyclopropyl)methyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1-methylcyclopropyl)methyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate(1200575-71-8)
• EPA Substance Registry System: (1-methylcyclopropyl)methyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate(1200575-71-8)

Safety Data

• Hazardous Substances Data: 1200575-71-8(Hazardous Substances Data)

Upstream product

• 1200575-68-3 Methyl 4-(2-piperidin-4-yl-4H-l,3-benzodioxin-6-yl)benzoatemethyl 4-(2-piperidin-4-yl-4H-1,3-benzodioxin-6-yl)benzoate 
• 2746-14-7 1-methylcyclopropanemethanol 
• 530-62-1 1,1'-carbonyldiimidazole 
• 2316-64-5 5-bromo-2-hydroxybenzyl alcohol 
• 138163-08-3 N-(benzyloxycarbonyl)piperidine-4-carboxaldehyde 
• 1200576-26-6 benzyl 4-{6-[4-(methoxycarbonyl)phenyl]-4H-1,3-benzodioxin-2-yl}piperidine-1-carboxylate 
• 1200575-51-4 benzyl 4-(6-bromo-4H-1,3-benzodioxin-2-yl)piperidine-1-carboxylate 

Downstream Products

• 1200575-74-1 4-[2-(1-{[(1-methylcyclopropyl)methoxy]carbonyl}piperidin-4-yl)-4H-1,3-benzo-dioxin-6-yl]benzoic acid 
• 1200572-92-4 (1-methylcyclopropyl)methyl 4-(6-{4-[(methylamino)carbonyl]phenyl}-4H-1,3-benzo-dioxin-2-yl)piperidine-1-carboxylate 

Relevant articles and documents

NEW GPR119MODULATORS

The application relates to compounds of Formula (Ia): and pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomersor N-oxides thereof. The application also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein- coupled receptor GPR119, such as diabetes, obesity and osteoporosis.